{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:36:44Z","timestamp":1780072604171,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","award":["CVV-450980"],"award-info":[{"award-number":["CVV-450980"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126445","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T09:58:43Z","timestamp":1729072723000},"page":"126445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study"],"prefix":"10.1016","volume":"42","author":[{"given":"Karina A.","family":"Top","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennady P.","family":"Shulha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Valiquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Isenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyumar","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126445_bb0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126445_bb0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126445_bb0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a Nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126445_bb0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.126445_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14740338.2022.2120607","article-title":"Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom","volume":"22","author":"Otero-Losada","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2024.126445_bb0030","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2024.01.099","article-title":"Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - a self-controlled case series analysis","volume":"42","author":"Morgan","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0035","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0040","article-title":"Association between COVID-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis","volume":"376","author":"Li","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.126445_bb0045","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2021.10.058","article-title":"Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: a case-control study","volume":"39","author":"Garcia-Grimshaw","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0050","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.29.21189","article-title":"Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012","volume":"20","author":"Bettinger","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.126445_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051254","article-title":"The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada","volume":"12","author":"Bettinger","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.126445_bb0060","series-title":"Vancouver, BC: Vaccine Evaluation Centre","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126445_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108786","article-title":"Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study","volume":"229","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.126445_bb0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell\u2019s palsy and SARS-CoV-2 vaccines","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126445_bb0080","series-title":"Safety Platform for Emergency Vaccines COVID-19 AESI list 5th update \u2013 October 2022. Decatur, GA: Brighton Collaboration","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126445_bb0085","first-page":"12","article-title":"Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort study. Frontiers","author":"Soe","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2024.126445_bb0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.26339","article-title":"Neurological events reported after COVID-19 vaccines: an analysis of VAERS","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2024.126445_bb0095","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1016\/j.vaccine.2022.10.084","article-title":"Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.","volume":"40","author":"Osowicki","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaoto.2023.0160","article-title":"Association of SARS-CoV-2 vaccination or infection with Bell palsy: a systematic review and Meta-analysis","volume":"149","author":"Rafati","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2024.126445_bb0105","series-title":"Evidence review of the adverse effects of COVID-19 vaccination and intramuscular vaccine administration","author":"National Academies of Sciences E, Medicine","year":"2024"},{"key":"10.1016\/j.vaccine.2024.126445_bb0110","series-title":"Public Health Agency of Canada COVID-19 vaccine safety in Canada. Ottawa, ON: Government of Canada","year":"2024"},{"key":"10.1016\/j.vaccine.2024.126445_bb0115","series-title":"Product Monograph: Vaxzevria\u2122 COVID-19 vaccine (ChAdOx1-S [recombinant])","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126445_bb0120","series-title":"Product monograph: Spikevax\u2122 Elasomeran mRNA vaccine","year":"2023"},{"key":"10.1016\/j.vaccine.2024.126445_bb0125","series-title":"Product monograph: Comirnaty COVID-19 vaccine, mRNA","year":"2023"},{"key":"10.1016\/j.vaccine.2024.126445_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CND.0000000000000432","article-title":"Small-Fiber neuropathy after vaccination with mRNA-1273 SARS-CoV-2 vaccine","volume":"24","author":"Bernheimer","year":"2023","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.vaccine.2024.126445_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/mus.27251","article-title":"Post COVID-19 vaccine small fiber neuropathy","volume":"64","author":"Waheed","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2024.126445_bb0140","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2022.12.031","article-title":"The v-safe after vaccination health checker: active vaccine safety monitoring during CDC\u2019s COVID-19 pandemic response","volume":"41","author":"Myers","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0145","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.vaccine.2020.03.018","article-title":"Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia\/paresthesia and severe headaches, Canada 2012\/13-2016\/17, the Canadian Vaccine Safety Network","volume":"38","author":"Ahmed","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0150","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.vaccine.2015.07.028","article-title":"Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: clinical features and risk factors","volume":"33","author":"De Serres","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"Bardage","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2024.126445_bb0160","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1016\/j.vaccine.2022.04.103","article-title":"A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: a Canadian Immunization Research Network study","volume":"40","author":"Psihogios","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126445_bb0165","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.15585\/mmwr.mm7144a3","article-title":"Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among persons aged \u226512 years - United States, August 31-October 23, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126445_bb0170","first-page":"12","article-title":"Safety and immunogenicity of the monovalent omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine in individuals \u226512 years old: a phase 2\/3 trial","author":"Gayed","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126445_bb0175","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1093\/infdis\/jiae067","article-title":"Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines","volume":"230","author":"Chalkias","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126445_bb0180","series-title":"Archived 14: Recommendations on the use of COVID-19 vaccines [2021-06-17]","author":"National Advisory Committee on Immunization","year":"2021"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:43:38Z","timestamp":1741887818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24011277"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126445","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126445"}}